statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	908
SG - Singapore	179
CN - Cina	101
SE - Svezia	73
IT - Italia	68
GB - Regno Unito	61
BR - Brasile	54
DE - Germania	54
HK - Hong Kong	45
FI - Finlandia	32
RU - Federazione Russa	27
VN - Vietnam	25
CA - Canada	17
FR - Francia	17
ID - Indonesia	12
PL - Polonia	9
BG - Bulgaria	8
KR - Corea	8
NL - Olanda	8
IN - India	7
AR - Argentina	6
AT - Austria	6
SI - Slovenia	6
ZA - Sudafrica	6
JP - Giappone	5
MX - Messico	5
LT - Lituania	4
MY - Malesia	4
IR - Iran	3
MA - Marocco	3
TR - Turchia	3
BD - Bangladesh	2
BE - Belgio	2
CZ - Repubblica Ceca	2
JO - Giordania	2
NP - Nepal	2
PY - Paraguay	2
VE - Venezuela	2
AD - Andorra	1
AE - Emirati Arabi Uniti	1
AG - Antigua e Barbuda	1
AZ - Azerbaigian	1
BO - Bolivia	1
CL - Cile	1
CO - Colombia	1
DO - Repubblica Dominicana	1
EC - Ecuador	1
ES - Italia	1
JM - Giamaica	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
NI - Nicaragua	1
NZ - Nuova Zelanda	1
PA - Panama	1
PE - Perù	1
PH - Filippine	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
UZ - Uzbekistan	1
Totale	1.799

Nome	#
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study	336
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison	240
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART	221
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering	211
Evaluation of HIV transmission clusters among natives and foreigners living in Italy	191
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort	165
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME	159
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy	156
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART	138
Totale	1.817

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	140	0	0	0	0	0	40	13	33	9	11	14	20
2021/2022	205	26	17	23	11	8	9	12	15	16	11	32	25
2022/2023	285	38	41	19	23	40	24	14	27	21	0	14	24
2023/2024	134	5	10	12	15	32	16	12	8	2	3	5	14
2024/2025	477	17	6	5	42	75	73	44	19	60	23	44	69
2025/2026	435	63	31	40	97	159	45	0	0	0	0	0	0
Totale													1.817